Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment

We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraaij, P. L. A., Verweel, G., van Rossum, A. M. C., Hartwig, N. G., Burger, D. M., de Groot, R.
Formato: Texto
Lenguaje:English
Publicado: Urban & Vogel 2007
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782124/
https://www.ncbi.nlm.nih.gov/pubmed/17565462
http://dx.doi.org/10.1007/s15010-007-6068-1
Descripción
Sumario:We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with side effects and discontinuation of therapy.

Ejemplares similares